Abundant stocks and lower prices continue to be features of the global food market. We look at how traders can protect their business in this challenging market environment.

The pharmaceutical industry continues to face an extremely challenging R&D environment and has yet to turn a corner in terms of its R&D value proposition.

The U.K. Advertising Standards Authority (ASA) has upheld a complaint against The Cornish Rum Co. against its ads marketing Dead Man's Fingers Hemp Rum.

The UK Food Standards Agency ("FSA") has issued a warning regarding counterfeit Glen's Vodka on sale in several locations around the UK.

Phase 2 and Phase 3 of checks and processes at the GB-EU border come into effect in April and July 2021. For Phase 2, additional agri-food products will require pre-notification and documentation.

The US National Toxicology Program has issued a toxicological profile for crystalline and amorphous silica, a compound linked to silicosis and lung cancer.

Plain packaging for cigarettes throughout the EU looks unlikely to happen.

The news is full of criticism for convenience food and drinks containing too much sugar or an equally undesirable mixture of E numbers and additives in the "light" and "diet" offerings.

Forecourt convenience stores should prepare for the new Calorie Labelling (Out of Home Sector) (England) Regulations 2021, the Government's latest weapon to address obesity, with statistics showing two-third of adults in the UK are overweight or obese

On February 5, 2025 Valneva SE ("Valneva") announced that the United Kingdom's Medicines and Healthcare products Regulatory Agency (MHRA) granted marketing authorization...

Two companies have applied to the Food Standards Agency ("FSA") for approval to market their novel food products in the EU under the Novel Food Regulation (EC) 258/97.

Earlier this week, the FDA issued two draft guidances on social media.

We recently reported (here) on the global challenge of antimicrobial resistance (AMR) and discussed how antimicrobial patent filings have faired over the last 10 years.

We recently reported (here) on the global challenge of antimicrobial resistance (AMR) and discussed how antimicrobial patent filings have faired over the last 10 years.

A newly discovered mode of action for a known compound can support patentable second medical use claims in Europe, even when the condition being treated is already known.

The TBA decided to remit the decision to the Opposition Division with the order to maintain the patent, EP1211926, on the basis of auxiliary request I, claim 1 of which is reproduced below.

On January 12, 2026, Sanofi announced that the European Commission approved its Teizeild (teplizumab) for delaying progression to stage 3 type 1 diabetes ("T1D") in adults and children eight years...

The NHS is now offering an injectable form of Keytruda (pembrolizumab) that can be administered in under two minutes, dramatically reducing treatment times from over an hour. This advancement, following last year's introduction of injectable nivolumab, promises to save hundreds of thousands of hours annually while cutting costs and improving patient care across cancer treatment services.

Earlier today, UK's Medicines and Healthcare products Regulatory Agency (MHRA) granted conditional marketing authorization to Vertex Pharmaceuticals and CRISPR Therapeutics...

Zentiva, a Portuguese generics company, sought and was granted marketing authorisation for a generic form of Boehringer Ingelheim's idiopathic pulmonary fibrosis drug Ofev (nintedanib) in August 2024